MichaelJDetkeMDPhD

Psychopharmacology

Gereral outpatient part-time at Indiana University School of Medicine (Clinical Associate Professor)

Dr. Detke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1996 - 2000
University of PennsylvaniaPhD, Psychology, 1988 - 1998
Perelman School of Medicine at the University of PennsylvaniaClass of 1996

PubMed

31 citations
Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years.
Vivien K. Burt, Madelaine M. Wohlreich, Craig H. Mallinckrodt, Michael J. Detke, John G. Watkin
Psychosomatics. 2005-07-01
67 citations
Antidepressant-like effects of cytidine in the forced swim test in rats.
William A. Carlezon, Andrea M. Pliakas, Aimee Parow, Michael J. Detke, Bruce M. Cohen
Biological Psychiatry. 2002-06-01
423 citations
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Lesley M. Arnold, Yili Lu, Leslie J. Crofford, Madelaine M. Wohlreich, Michael J. Detke
Arthritis and Rheumatism. 2004-09-01

Lighthouse Pharmaceuticals Announces Progression of LHP588 Clinical Development Program in Alzheimer's DiseaseMay 10th, 2023
Cortexyme, SQZ, Others Present New Insights into Alzheimer's and Parkinson'sMarch 21st, 2022
Cortexyme Provides New GAIN Trial Data at AD/PD 2022 Demonstrating Potential Benefit of Lysine Gingipain Inhibition in Mild to Moderate Alzheimer’s PopulationMarch 21st, 2022
Join now to see all